Loading organizations...
Loading organizations...
Novel immunotherapies through innovative technologies and partnerships.
Amberstone Biosciences has raised $12.0M across 1 funding round.
Amberstone Biosciences has raised $12.0M in total across 1 funding round.
Amberstone Biosciences has raised $12.0M in total across 1 funding round.
Amberstone Biosciences's investors include Xin Huang, Peter Wu, ChangRong Capital, Lifespan Investments.
Amberstone Biosciences has raised $12.0M across 1 funding round. Most recently, it raised $12.0M Series A in January 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 3, 2022 | $12.0M Series A | Xin Huang, Peter Wu | ChangRong Capital, Lifespan Investments |